Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Galectin Therapeutics Q3 EPS $(0.14), Same YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.14) per share. This is unchanged from the same period last year.
byBenzinga Newsdesk
November 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.14) per share. This is unchanged from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With Snap Shares?

By Henry Khederian
March 8, 3:23 PM
Snap Inc (NYSE: SNAP) shares are trading lower by 4.18% to $11.23 Wednesday as the stock pulls back following recent strength. The stock gained in recent sessions amid unveiling of a U.S. Senate bill that could ban TikTok.

SNAP

Read More

Preview: StepStone Group’s Earnings

By Benzinga Insights
August 3, 11:18 AM
StepStone Group (NASDAQ:STEP) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that StepStone Group will report an earnings per share (EPS) of $0.32.

STEP